|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Amblyopia | |||||
| 2 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Eye Diseases | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Sensation Disorders | |||||
| Signs and Symptoms | |||||
| Vision Disorders | |||||
| 3 | Interventions listed in this trial | ||||
| Eye patch | |||||
| spectacles | |||||
| atropine | |||||
| 4 | Sponsors listed in this trial | ||||
| National Eye Institute (NEI) | |||||